BOSTON –For nearly 70 years scientists have known that caloric restriction prolongs life. In everything from yeast to primates, a significant decrease in calories can extend lifespan by as much as one-third. But getting under the hood of the molecular machinery that drives this longevity has remained elusive. Now, reporting in the September 21 issue of the journal Cell, researchers from Harvard Medical School, in collaboration with scientists from Cornell Medical School and the National Institutes of Health, have discovered two genes in mammalian cells that act as gatekeepers for cellular longevity. When cells experience certain kinds of stress, such as caloric restriction, these genes rev up and help protect cells from diseases of aging. ‘We’ve reason to believe now that these two genes may be potential drug targets for diseases associated with aging,’ says David Sinclair, associate professor of pathology at Harvard Medical School and senior author on the paper. The new genes that Sinclair’s group have discovered, in collaboration with Anthony Sauve of Cornell Medical School and Rafael de Cabo of NIH, are called SIRT3 and SIRT4. They are members of a larger class of genes called sirtuins. (Another gene belonging to this family, SIRT1, […]
Friday, September 21st, 2007
Researchers Find Connection Between Caloric Restriction and Longevity
Author:
Source: Harvard/EurekAlert!
Publication Date: 20-Sep-07
Link: Researchers Find Connection Between Caloric Restriction and Longevity
Source: Harvard/EurekAlert!
Publication Date: 20-Sep-07
Link: Researchers Find Connection Between Caloric Restriction and Longevity
Stephan: Thanks to Damien Broderick.
For a copy of the paper, please contact public_affairs@hms.harvard.edu
Full Citation:
Cell, Volume 130, Issue 5, September 21, 2007
'Nutrient-Sensitive Mitochondrial NAD+ Levels Dictate Cell Survival'
Hongying Yang(1,6), Tianle Yang(2), Joseph A. Baur(1), Evelyn Perez(3), Takashi Matsui(5), Juan J. Carmona(1), Dudley W. Lamming(1), Nadja C. Souza-Pinto(4), Vilhelm A. Bohr(4), Anthony Rosenzweig(5), Rafael de Cabo(3), Anthony A. Sauve(2), and David A. Sinclair(1)
1-Department of Pathology, Paul F. Glenn Laboratories, Harvard Medical School, Boston, MA
2-Department of Pharmacology, Weill Medical College of Cornell University, New York, NY
3-Laboratory of Experimental Gerontology
4-Laboratory of Molecular Gerontology, National Institute on Aging, Institutes of Health, Baltimore, MD
5-Cardiovascular Division, Beth Israel Deaconess Medical Center, Boston, MA
6-Present address: Sirtris Pharmaceuticals, Cambridge, MA